Terns Pharmaceuticals (TERN) Debt to Equity (2020)
Terns Pharmaceuticals (TERN) has disclosed Debt to Equity for 1 consecutive years, with -$0.11 as the latest value for Q4 2020.
- For the quarter ending Q4 2020, Debt to Equity changed N/A year-over-year to -$0.11, compared with a TTM value of -$0.11 through Dec 2020, changed N/A, and an annual FY2020 reading of -$0.11, changed N/A over the prior year.
- Debt to Equity was -$0.11 for Q4 2020 at Terns Pharmaceuticals.
- Across five years, Debt to Equity topped out at -$0.11 in Q4 2020 and bottomed at -$0.11 in Q4 2020.